Anti-Monocyte Antigen antibody [IPO-M6] (STJ16100825)

SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG1k
ImmunogenA BALB/c mouse was immunized with human cell line HL-60. Fusion partner: P3-X63-Ag8.653.
STJ16100825
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionMouse monoclonal anti-Monocyte antigen for use in FC, IHC and IP in Human samples. Datasheet included with dilution recommendations, and related reagents.
ApplicationsFC/IHC/IP
HostMouse
ReactivityHuman
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ClonalityMonoclonal
Clone IDIPO-M6
IsotypeIgG1k
ConjugationUnconjugated
ConcentrationCan be provided as 100 µg/mL, 500 µg/mL or 1mg/mL.
PurificationAffinity purified from tissue culture.
Dilution RangeFlow cytometry (0.5-1.0 µg/million cells in 0.1 ml). Immunohistology (1-2 µg/ml for 30 min at RT). Immunoprecipitation (1-2 µg/million cells in 1ml anti mouse coated Sepharose-4B suspension).
FormulationPBS with 0.02% Sodium Azide.
Storage InstructionStore for up to 1 year at 2-8°C upon receipt.

Target Information

ImmunogenA BALB/c mouse was immunized with human cell line HL-60. Fusion partner: P3-X63-Ag8.653.

Additional Info

Background IPO-M6 reacts with human leukemia cell line HL-60 and immuno-precipitates two proteins with MW of 48 and 52 kDa. IPO-M6 does not stain B cell lines Daudy, PHS, Namalwa, RPMI-1788 and T-cell lines CCRF-HSB2, Jurkat and Molt-4. IPO-M6 can be applied for staining of monocytes and up to 10 % of lymphocytes from peripheral blood of healthy donors. Blast cells of patients with AMMonL (M5 following FAB classification) , AMMonL (M4) and hairy cells leukemia are IPO-M6 positive. The antigen, defined by IPO-M6, is particularly expressed on blood cells from patients with infectious mononucleosis and CLL. Histiocytes and macrophages are also positive. Malignant cells from patients with AML (M1 and M2) , T-ALL, B ALL are IPO-M6 negative.

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins